GlassScriptPhysician profile
Simone D Willingham
NPI 1922194117
$1,747.36
in general payments reported to CMS, 2019-2025
12 companies · $564 in 2025
The $564 reported for 2025 was more than what 86% of Occupational Medicine providers received nationally (typical 2025 total: $53.66).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.61 · 2022: $122 · 2023: $765 · 2024: $255 · 2025: $564.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,584.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $278.67 | 2023-2025 | Ozempic, Rybelsus |
| Medtronic, INC. | $274.11 | 2023 | Linq II |
| Genzyme Corporation | $254.88 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $125.22 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $125.00 | 2025 | Austedo Xr |
| Abbott Laboratories | $121.71 | 2022 | |
| Kyowa Kirin, INC. | $120.20 | 2025 | |
| Amgen INC. | $115.69 | 2023 | |
| Janssen Scientific Affairs, LLC | $110.68 | 2023 | Xarelto |
| Alexion Pharmaceuticals, INC. | $100.04 | 2023 | Ultomiris |
| Angiodynamics, INC. | $79.55 | 2025 | Nanoknife |
| Scilex Pharmaceuticals INC. | $41.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simone Willingham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.